Arbutus Biopharma Corp
Ticker: 1447028
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 179.13+33698.1% | 0.53-95.1% | 10.74+510.2% | 1.76+31.3% | 1.34-22.5% | 1.73+13.1% | 1.53-67.2% | 4.66 |
| Total Income | 179.13+33698.1% | 0.53-95.1% | 10.74+510.2% | 1.76+31.3% | 1.34-22.5% | 1.73+13.1% | 1.53-67.2% | 4.66 |
| EXPENSES | ||||||||
| Expenditure | 10.22+11.2% | 9.19-0.6% | 9.25-66.3% | 27.46+20.5% | 22.78-2.3% | 23.31+11.5% | 20.90-20.3% | 26.22 |
| Tax | 0.00 | — | — | — | — | — | — | 0.00 |
| PROFIT | ||||||||
| PBT | — | — | — | — | — | — | — | -20.10 |
| Net Profit | 169.70+2292.5% | -7.74-407.1% | 2.52+110.3% | -24.53-24.4% | -19.72+0.4% | -19.80-10.7% | -17.88+11.0% | -20.10 |
| KEY METRICS | ||||||||
| OPM % | 94.30%+194.30pp | -100.00%-113.85pp | 13.86%+113.85pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 94.73%+194.73pp | -100.00%-123.49pp | 23.49%+123.49pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.88+2300.0% | -0.04-500.0% | 0.01+107.7% | -0.13-30.0% | -0.10+9.1% | -0.11-10.0% | -0.10+16.7% | -0.12 |
Corporate Events
Board MeetingABUS
202626May
Board Meeting
2026 Annual General and Special Meeting of Shareholders to e…
SEC Filing ↗